Oncology & Cancer

Oral chemo still too expensive even after doughnut hole closes

Access to expensive oral chemotherapy drugs will still be out of reach for millions of Americans with Medicare coverage, even when one of the most touted reforms in health care coverage takes place in 2020. The analysis, ...


Aetna to buy Humana as health insurer landscape shifts

Aetna aims to spend about $35 billion to buy rival Humana and become the latest health insurer bulking up on government business as the industry adjusts to the federal health care overhaul.


Reexamining the impact of Medicare Part D on health and savings

For years, the Medicare prescription drug benefit Part D has been credited with positively impacting national trends in health outcomes and medical services. But a recent study led by Northeastern associate professor Becky ...

Arthritis & Rheumatism

Patients grapple with high cost of arthritis medications

The first national investigation of Medicare coverage of biologic disease modifying drugs (DMARDs) found that in starting a single biologic DMARD, patients face more than $2,700 in copayments each year before receiving relief ...

page 3 from 9